Concepedia

Sharon Merims

SM

Statistics

Publications

17

Citations

567

H-Index

15

Active since

2004

Affiliations

Hadassah Medical Center(Current)

Hebrew University of Jerusalem

Hadassah Academic College

Weizmann Institute of Science

Sheba Medical Center

Sharon Merims is an author at Hadassah Medical Center specializing in immunology, oncology, and cancer immunotherapy.

ORCID

Publications per year

2004–2023

17

Publications

17

MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4

Gil Katz, Roi Gazit, Tal I. Arnon et al. · The Journal of Immunology · 2004 · 99 citations · Full text

, , +16

Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy

Sharon Merims, Xujian Li, Betty Joe et al. · Leukemia · 2011 · 65 citations

, , +17

Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study

Reut Hadash‐Bengad, Emma Hajaj, Shiri Klein et al. · Frontiers in Oncology · 2020 · 45 citations · Full text

, , +17

Physical properties of gold nanoparticles affect skin penetration via hair follicles

Nethanel Friedman, Arie Dagan, Jhonathan Elia et al. · Nanomedicine Nanotechnology Biology and Medicine · 2021 · 45 citations · Full text

, , +17

SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint

Emma Hajaj, Galit Eisenberg, Shiri Klein et al. · eLife · 2020 · 41 citations · Full text

, , +17

1–5 of 17